Avalo Therapeutics
AVTX
AVTX
12 hedge funds and large institutions have $210K invested in Avalo Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 9 reducing their positions, and 19 closing their positions.
Holders
12
Holders Change
-16
Holders Change %
-57.14%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
9
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
N
1
Natixis
Paris,
France
|
$43.3K |
| 2 |
FIA
2
FNY Investment Advisers
New York
|
$4K |
| 3 |
3
JPMorgan Chase & Co
New York
|
$18 |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TSS
26
Two Sigma Securities
New York
| – | – | -15,601 | Closed |
|
27
Northern Trust
Chicago,
Illinois
| – | – | -10,836 | Closed |
|
28
Fifth Third Bancorp
Cincinnati,
Ohio
| – | – | -279 | Closed |
|
|
MAM
29
Meeder Asset Management
Dublin,
Ohio
| – | – | -62 | Closed |
|
|
NFSG
30
Newbridge Financial Services Group
Boca Raton,
Florida
| – | – | -10 | Closed |
|
|
PA
31
Parallel Advisors
San Francisco,
California
| – | – | -1 | Closed |
|
|
CFGS
32
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|